Clinical Report: Quantitative Analysis of Interstitial Lung Disease via AI-Enhanced Chest CT

Overview

This study evaluates the efficacy of an AI-based chest HRCT analysis tool in quantifying interstitial lung disease (ILD) in patients with idiopathic inflammatory myopathies (IIMs). The findings indicate a strong correlation between AI assessments and expert visual evaluations, highlighting the potential of AI in improving diagnostic accuracy.

Background

Interstitial lung disease is a significant complication in patients with idiopathic inflammatory myopathies, affecting up to 40% of this population and leading to worsened prognoses. Traditional HRCT assessments are often subjective and prone to variability, necessitating more objective and reproducible methods for evaluation. The integration of AI in imaging analysis presents a promising avenue for enhancing diagnostic precision in ILD associated with IIMs.

Data Highlights

Key Findings

• The AI-based HRCT analysis tool demonstrated a high correlation with expert visual evaluations.
• AI metrics provided objective quantification of ILD lesions, reducing inter-observer variability.
• Quantitative HRCT metrics were associated with disease severity and functional impairment.
• AI analysis may facilitate earlier detection of ILD in IIM patients.
• Integration of AI tools could standardize ILD assessments across different clinical settings.

Clinical Implications

The use of AI-enhanced HRCT analysis can improve the accuracy and consistency of ILD assessments in patients with IIMs. Clinicians may consider adopting these technologies to enhance diagnostic capabilities and inform treatment decisions more effectively.

Conclusion

AI-based analysis of chest HRCT scans shows promise in providing reliable quantification of ILD in IIM patients, potentially transforming clinical practice in this area. Further studies are warranted to validate these findings across broader populations.

References

1. Clinical Rheumatology, 2023 -- A Quantitative Scoring System Using Computed Tomography for Diagnosing Interstitial Lung Disease Related to Rheumatoid Arthritis
2. Clinical Rheumatology, 2023 -- Evaluating Semi-Quantitative and Quantitative Approaches for Predicting Progression in Interstitial Lung Disease Linked to Rheumatoid Arthritis
3. European Radiology, 2023 -- CT Imaging of Emphysema, Airway Wall Thickness, and Mucus Obstruction in Alpha-1-Antitrypsin Deficiency: Correlation with Clinical Outcomes
4. ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease, 2025
5. European Radiology — Identifying Risk Factors and Prognostic Markers for Progressive Fibrosing Interstitial Lung Disease Using Deep Learning Techniques for CT Imaging Analysis
6. Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement
7. ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease
8. https://rheumatology.org/api/asset/bltaedebda97a351d47